Bryn Mawr Trust Advisors LLC bought a new stake in shares of The Allstate Corporation (NYSE:ALL – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 5,875 shares of the insurance provider’s stock, valued at approximately $1,398,000.
A number of other large investors also recently bought and sold shares of ALL. Coldstream Capital Management Inc. raised its stake in shares of Allstate by 0.6% during the 4th quarter. Coldstream Capital Management Inc. now owns 7,809 shares of the insurance provider’s stock worth $1,625,000 after buying an additional 50 shares during the period. Compound Planning Inc. grew its stake in Allstate by 1.6% in the 4th quarter. Compound Planning Inc. now owns 3,216 shares of the insurance provider’s stock valued at $669,000 after acquiring an additional 50 shares during the period. Cullen Frost Bankers Inc. increased its holdings in Allstate by 0.9% in the 4th quarter. Cullen Frost Bankers Inc. now owns 5,815 shares of the insurance provider’s stock worth $1,210,000 after acquiring an additional 52 shares in the last quarter. Root Financial Partners LLC increased its holdings in Allstate by 4.7% in the 1st quarter. Root Financial Partners LLC now owns 1,170 shares of the insurance provider’s stock worth $243,000 after acquiring an additional 53 shares in the last quarter. Finally, Montag A & Associates Inc. raised its position in Allstate by 10.2% during the fourth quarter. Montag A & Associates Inc. now owns 596 shares of the insurance provider’s stock worth $125,000 after acquiring an additional 55 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.
Allstate Price Performance
Allstate stock opened at $261.26 on Friday. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The company has a 50-day moving average price of $246.52 and a 200 day moving average price of $222.83. The Allstate Corporation has a 12-month low of $188.08 and a 12-month high of $277.22. The stock has a market cap of $66.06 billion, a P/E ratio of 5.22, a PEG ratio of 0.40 and a beta of 0.16.
Allstate Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be given a $1.08 dividend. This represents a $4.32 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate’s payout ratio is currently 8.63%.
Insider Buying and Selling at Allstate
In related news, Director Andrea Redmond sold 2,225 shares of the business’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $202.91, for a total transaction of $451,474.75. Following the completion of the transaction, the director directly owned 2,225 shares of the company’s stock, valued at $451,474.75. The trade was a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider John E. Dugenske sold 32,996 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $269.33, for a total value of $8,886,812.68. Following the transaction, the insider directly owned 13,054 shares of the company’s stock, valued at approximately $3,515,833.82. This represents a 71.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 92,996 shares of company stock valued at $24,543,894 over the last three months. 1.55% of the stock is currently owned by company insiders.
More Allstate News
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Analyst earnings estimates were raised. Dowling & Partners increased its FY2026 EPS estimate for Allstate to $35.50 from $30.50, reinforcing expectations for continued profitability. FY2026 EPS estimates article
- Positive Sentiment: JPMorgan reportedly expects further upside. The analyst maintained an overweight rating and raised its price target to $292 from $282, supporting the bullish case following Allstate’s recent earnings beat. JPMorgan analyst article
- Positive Sentiment: Allstate is investing in quantum computing. CEO Tom Wilson said the insurer plans to expand its current 10-person quantum team so it can build expertise and potentially gain a competitive advantage as the technology matures. The investment is strategically positive, although financial benefits are likely long term. Allstate quantum computing article
- Positive Sentiment: Claims operations are receiving additional investment. Allstate opened a 33,000-square-foot training campus in Dallas for its 23,000 claims professionals. Improved claims accuracy and customer service could support retention and operating efficiency. Allstate Claims University announcement
- Neutral Sentiment: Recent earnings remain a major backdrop. Allstate’s latest quarter produced $8.99 in EPS versus the $6.06 consensus estimate, while revenue rose 11.8% year over year to $15.43 billion. However, the stock is trading near its 52-week high, increasing sensitivity to any signs that profitability may moderate.
- Negative Sentiment: Insiders sold substantial holdings. COO Mario Rizzo sold 56,225 shares for approximately $14.9 million, reducing his direct position by 40.6%. Separate reports also disclosed a sizable sale by John Dugenske, potentially weighing on investor sentiment. Allstate insider sales article
- Negative Sentiment: Allstate lost an Ontario coverage challenge. Definity prevailed in court over Allstate’s excluded-driver coverage position, creating a potential legal and claims-related concern in the Canadian market. Ontario court coverage challenge article
- Negative Sentiment: Valuation concerns remain. One analysis argues Allstate’s share price assumes a 94.1% combined ratio that the company has never sustained, raising questions about whether its recent operating returns can persist.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the stock. Piper Sandler upped their price target on shares of Allstate from $268.00 to $300.00 and gave the stock an “overweight” rating in a research report on Monday, August 10th. Wall Street Zen upgraded Allstate from a “hold” rating to a “buy” rating in a report on Monday, July 20th. Citigroup lowered Allstate from a “neutral” rating to a “sell” rating and boosted their price objective for the stock from $226.00 to $240.00 in a research note on Tuesday. Mizuho increased their target price on Allstate from $255.00 to $272.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. Finally, UBS Group raised their target price on Allstate from $261.00 to $275.00 and gave the company a “neutral” rating in a research report on Monday. Three research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $265.53.
View Our Latest Research Report on Allstate
Allstate Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Further Reading
- Five stocks we like better than Allstate
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
